NewEdge Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $98.8M | Buy |
|
|||||
|
2025
Q1 | $101M | Buy |
|
|||||
|
2024
Q4 | $93.2M | Sell |
|
|||||
|
2024
Q3 | $108M | Sell |
|
|||||
|
2024
Q2 | $112M | Buy |
|
|||||
|
2024
Q1 | $83.1M | Buy |
|
|||||
|
2023
Q4 | $60.2M | Buy |
|
|||||
|
2023
Q3 | $39.5M | Buy |
|
|||||
|
2023
Q2 | $31.6M | Buy |
|
|||||
|
2023
Q1 | $23.3M | Sell |
|
|||||
|
2022
Q4 | $11.7M | Buy |
|
|||||
|
2022
Q3 | $19.8M | Sell |
|
|||||
|
2022
Q2 | $20.3M | Buy |
|
|||||
|
2022
Q1 | $15.2M | Buy |
|
|||||
|
2021
Q4 | $13.3M | Buy |
|
|||||
|
2021
Q3 | $8.74M | Buy |
|
|||||
|
2021
Q2 | $7.35M | Buy |
|
|||||
|
2021
Q1 | $5.87M | Sell |
|
|||||
|
2020
Q4 | $6.14M | Sell |
|
|||||
|
2020
Q3 | $21.2M | Buy |
|
|||||
|
2020
Q2 | $6.23M | Buy |
|
|||||
|
2020
Q1 | $5M | Buy |
|
|||||
|
2019
Q4 | $4.08M | Sell |
|
|||||
|
2019
Q3 | $3.43M | Buy |
|
|||||
|
2019
Q2 | $1.34M | Buy |
|
|||||
|
2019
Q1 | $1.54M | Sell |
|
|||||
|
2018
Q4 | $1.4K | Buy |
|
|||||
|
2018
Q3 | $1.2M | Sell |
|
|||||
|
2018
Q2 | $987 | Sell |
|
|||||
|
2018
Q1 | $8.17M | Buy |
|
|||||
|
2017
Q4 | $7.66M | Buy |
|
|||||
|
2017
Q3 | $7.19M | Buy |
|
|||||
|
2017
Q2 | $1.92M | Buy |
|
|||||
|
2017
Q1 | $1.85M | Buy |
|
|||||
|
2016
Q4 | $254K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $454K | Buy |
|